Born 1948. Member of the board since 2014. M.Sc. from Stockholm School of Economics, MBA from University of Berkeley, California. Mats Persson has extensive experience as CEO at several Swedish companies. With a focus on implementing major organizational changes and increasing profitability. During 1996-2012 Mats Persson served as main shareholder in Neuman and Nydahl, offering qualified strategy counselling, leadership development and recruitment at managerial level to leading companies in Sweden, including Incentive, Skanska, Swedbank, Boliden, Loomis, Nynäs and Pharmacia. Mats Persson has over 30 years of board work in listed and unlisted companies, from a broad spectrum of Swedish Industry including Life Science.
Born 1951. Member of the Board since 2014. Professor in anesthesiology and intensive care since 1999 at the Department of Clinical Science, Intervention and Technology at the Karolinska Institute. Dr. Sollevi received his medical degree in 1976 and became a licensed physician in 1978. He received his PhD in 1981. After two years as Associate Professor of Pharmacology, he became a docent in anesthesiology and intensive care in 1986. During a long period, from 1982 to 2008, Dr. Sollevi has led a research group that conducted basic studies as well as clinical examinations regarding effects and clinical applicability of the endogenous substance adenosine.
Born 1959. Member of the board since 2014. M.Sc. from Stockholm School of Economics. Ulf has 25 years of experience in the pharmaceutical industry, mostly in international and global roles. Most recently 10 years as President Europe in AstraZeneca, based in Brussels, followed by the role as Global Marketing Director at the company headquarters in London. Earlier in his career he also held sales and marketing roles in the US. Board member in RISE (Research Institutes of Sweden), a government body with 2500 employees doing front line research in collaboration with industry, N-side, Leuwen Belgium, a consulting firm in mathematical analysis, Nobelux, a trade org to support trade between Sweden and Belux. Former member of the board at AB Blåklader (working wear) and Chairman in the AZ Germany Supervisory Board. Industrial Advisor at EQT.
Maria Homman holds a PhD in polymer technology and has been a manager within R&D at AkzoNobel (initially Casco Adhesives) for 10 years, with responsibility for the development of products from idea to market, as well as customer support. Dr. Maria Homman was previously Member of the Board (2006-2011) and Chairman of the Board (2006-2008).
Mr. Homman has a M.Sc. in Chemistry and B.Sc. in biology from Uppsala University in 1998. Mohammed has been the driving force behind the development of the virus analysis technique and VN-180. He has received several national and international awards in recognition of his entrepreneurship and innovative research achievements. In 2003 Mohammed was chosen as one of the “Leaders of Tomorrow” by the Academy of Achievement, USA.